(1 mM), verapamil (1 mM), u-conotoxin (1 mM), and bepridil (10 mM). Noticeably the effect of curcumin was not observed when curcumin and choline were co-applied without curcumin pre-incubation. The effect of curcumin on choline-induced Ca 2þ transients was not reversed by pre-incubation with inhibitors of protein C, A, and CaM kinases. Metabolites of curcumin such as tetrahydrocurcumin, demethylcurcumin, and didemethylcurcumin also caused potentiation of choline-induced Ca 2þ transients.
Introduction
Curcumin, a poly phenolic compound isolated from turmeric, has been demonstrated to have various pharmacological activities ranging from anti-inflammatory, anti-cancer, anti-oxidant effects to anti-atherosclerotic, anti-microbial, and wound healing actions (Kunnumakkara et al., 2016) . Importantly, in recent years, curcumin has been shown to have beneficial effects in alleviating cognitive deficits in neurodegenereative disorders such as Alzheimer's and Parkinson's diseases (Ji and Shen, 2014; Goozee et al., 2016; Kunnumakkara et al., 2016) . Although therapeutic effects of curcumin on several pathological conditions and animal disease models have been well documented, the molecular mechanism of curcumin effects in cells are poorly understood.
These diverse pharmacological activities of curcumin are based on its chemical features and complex molecular structure, as well as its ability to interact with multiple signaling molecules (Zhang et al., 2014) . To date, several membrane proteins including protein kinases, enzymes, transporters and ion channels have been identified as targets of curcumin (Zhang et al., 2014; Kunnumakkara et al., 2016) .
Nicotinic acetylcholine (nACh) receptors are important members of the ligand-gated ion channel family that includes GABA A , glycine, and 5-HT 3 receptors. The homomeric a 7 nACh receptor subtype is abundantly expressed in the central nervous system and periphery and plays a key role in synaptic plasticity and disease (Albuquerque et al., 2009) . Neuronal a 7 -nACh receptors are recognized targets for drug development in several pre-clinical models of neuro-degenerative disorders including Alzheimer's disease (Thomsen et al., 2010) . In the present study, we have investigated the effects of curcumin on human a 7 -nACh receptors expressed in SH-EP1 cells. We provide novel evidence that curcumin potentiates intracellular Ca 2þ transients of the ligand-gated a 7 -nACh receptors.
Materials and methods

SH-EP1 cell culture
The SH-EP1 cells stably expressing the human a7 nAChR were a gift from Dr. R Lukas (Barrow Neurological Institute, Phoenix, AZ). Culturing of SH-EP1 cells was described earlier (Spivak et al., 2007; Sultan et al., 2017) . Briefly, cells were grown on 35-mm dishes in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat inactivated horse serum, 5% fetal bovine serum, 1 mM sodium pyruvate, 100 U/ml penicillin G, 100 mg/ml streptomycin, 0.25 mg/ml amphotericin B, 0.4 mg/ml hygromycin B, and 0.25 mg/ml Zeocin (all from Invitrogen). For measurements of intracellular [Ca 2þ ], cells were plated at a density of 2 Â 10 5 cells per well into 96-well plates and were kept for 2e3 days at 37 C in an atmosphere of 5% CO 2 saturated with H 2 O. Experiments were performed at room temperature (24 ± 2 C).
Measurement of intracellular [Ca 2þ ]
The SH-EP1 cells were loaded with Krebs-HEPES (in mM: 144 NaCl, 5.9 KCl, 1.2 MgCl 2 , 2 CaCl 2 , 11 D-glucose, 10 HEPES, pH 7.4) containing 10 mM fluo-4 AM (Molecular Probes, Life Technologies, Paisley, UK) for 45 min at 37 C in the dark. After this incubation period, cells were washed twice with Krebs-HEPES at room temperature in the dark. Atropine (1 mM) was included in all test and incubation solutions. Changes in fluorescence (excitation 485 nm, emission 520 nm) were measured using a fluorescent plate reader (Fluostar, BMG Labtech Inc., Cary, NC, USA). Basal levels of fluorescence were monitored before adding stimulation solution (1 mM choline or 100 mM ACh) by using an automatic dispenser.
After stimulation, changes in fluorescence were measured for 30 sec. To normalize fluo-4 signals, responses from each well were calibrated by measuring maximum and minimum fluorescence values. At the end of each experiment, addition of 75 ml of 5% Triton X-100 (F max ) was followed by addition of 50 ml of 1 M MnCl 2 (F min ).
Data were calculated as a percentage of F max -F min and presented as % of F max -F min or area under fluorescence curve (AUC). Go-6983, KT-5720, KN-62; nifedipine, verapamil, bepridil, u-conotoxin MVIIC, and a-bungarotoxin were purchased from Tocris (TocrisBio-Techne, Minneapolis, MN). Curcumin metabolites were purchased from Sigma (Sigma, St. Louis, MO).
Radioligand binding experiments
The SH-EP1 cells grown to confluence in 35-mm dishes were collected by scraping in 50 mM HEPES buffer, pH 7.4, containing 1 mM MgCl 2 , 2.5 mM CaCl 2 , 0.1% (w/v) bovine serum albumin, 0.025% (w/v) bacitracin and 0.025% (w/v) sodium azide. Subsequently, cells were centrifuged at 1 200 r.p.m. for 15 min at 4 B C. After removal of the supernatant, the cells were frozen at À80 B C until the day of the experiment. For each binding assay experiment, the cells were resuspended in 50 mM Tris-HCl buffer (pH 7.4) containing 120 mM NaCl, 5 mM EDTA, 1.5 mM MgCl 2 and 5 mM KCl, using a Polytron tissue homogenizer at setting 4 for 20 s. Cell sus- 
Statistical analysis
Data were calculated as the mean ± standard error means (S.E.M.). One way ANOVA was conducted to determine statistical significance between measurements in different groups. When differences existed, pair-wise post-hoc comparisons using the Bonferroni correction were completed. The P values < 0.05 were considered significant. Concentration-response curves were obtained by fitting the data to the logistic equation,
where x and y are concentration and response, respectively, E max is the maximal response, EC 50 is the half-maximal concentration, and n is the slope factor (apparent Hill coefficient).
Results
We examined the effects of curcumin in Fluo-4 loaded SH-EP1 cells stably transfected with human a 7 -nACh receptor. Application of curcumin alone in the concentrations up to 100 mM for 30 sec. did not induce any detectable change in intracellular Ca 2þ levels in (n ¼ 14 from 3 separate experiments). Application of choline
(1 mM), a selective agonist for a 7 -nACh receptor (Albuquerque et al., 2009 ) for 30 sec. induced a rapid increase in intracellular Ca 2þ concentrations (Fig. 1A, control) . Application of non-selective cholinergic agonist, ACh was also found to produce a similar rise in intracellular Ca 2þ (n ¼ 12; data not shown). Calcium transients induced by choline was completely inhibited by 10 min preincubation with 10 mM methyllycaconitine, a selective antagonist for a 7 -nACh receptor ( Fig. 1A and B) . Pre-incubation with 1 mM curcumin (for 10 min) was associated with a significant potentiation (2.2 fold, n ¼ 12, ANOVA, P ¼ .001) of the choline-induced Ca 2þ transient in the cells (Fig. 1A and B channel antagonist, bepridil (10 mM). In the presence of these antagonists (n ¼ 15, P ¼ .068 for nifedipine and n ¼ 19, P ¼ .086 for verapamil; n ¼ 11, P ¼ .074 for u-conotoxin and n ¼ 14, P ¼ .083 for bepridil) curcumin (10 mM) continued to potentiate cholineinduced Ca 2þ transients ( Fig. 2A and 2B ). In the concentrations used in this study, these Ca 2þ channel antagonists themselves did not have any effect on choline-induced Ca 2þ transients (n ¼ 11e14, ANOVA, P > .05). Co-application of curcumin and choline, without pre-incubation with curcumin, was not associated with a rise in the cholineinduced Ca 2þ transients (n ¼ 18, ANOVA, P ¼ .512) suggesting that the effects of curcumin on nACh receptor Ca 2þ signal require receptor priming by additional cellular mechanisms such as kinases. We therefore investigated the involvement of protein kinases A, C, and Ca 2þ -calmodulin dependent kinase (CaM-kinase), which are known to regulate functions of ligand-gated ion channels (Zhang et al., 1995; Talwar and Lynch, 2014) , in curcumin's effect on a 7 -nACh receptor Ca 2þ response. A 30 min. pretreatment with 3 mM Go-6 983 (Go; protein kinase C specific inhibitor; Young et al., 2005) , 10 mM KT-5 720 (KT; protein kinase A specific inhibitor; Cabell and Audesirk, 1993), or 10 mM KN-62 (KN; CaM kinase II specific inhibitor, Tokumitsu et al., 1990 ) was found to have no effect on curcumin (10 mM) mediated potentiation of the choline (1 mM)-induced Ca 2þ response (ANOVA; n ¼ 18e21; P ¼ .001 for Go, KT, and KN groups). The results of these experiments were presented in Fig. 3A . After 30 min. pretreatment, protein kinase inhibitors (Go, KT, KN) at the concentrations used in this study did not cause any alterations on the choline-induced Ca 2þ transients
In vivo curcumin is known to be metabolized to compounds such as tetrahydrocurcumin (THC), demethylcurcumin (DMC), and didemethylcurcumin (DDMC) (Anand et al., 2007) . We tested the effects of these curcumin metabolites on choline-induced Ca 2þ transients in SH-EP1 cells. Our findings indicate that these curcumin metabolites (at 10 mM concentrations) can also significantly (ANOVA; n ¼ 12e16; P ¼ .001 for THC, DMC, and DDMC groups) potentiate choline-induced Ca 2þ transients in this cell line (Fig. 3B) . (Fig. 4B) indicated that, in the absence and presence of curcumin (10 mM), there is no significant alteration in a B max values. In the absence and presence of curcumin, B max values were 0.746 ± 0.065 pmol/mg and 0.781 ± 0.087 pmol/mg, respectively (n ¼ 9 measurement from 3 experiments, ANOVA, P ¼ .073).
Discussion
In the present study, we provide novel evidence that curcumin potentiates the function of human a 7 -nACh receptors expressed in SH-EP1 cells. Potentiation by curcumin occurs in a time and concentration dependent manner, but appears independent of channel phosphorylation by protein A, C, and CaM type kinases. The findings underscore a role for curcumin in the regulation of a 7 -nACh receptor signaling in various cells.
Our findings suggest that the application of curcumin alone is not sufficient to promote a detectable change in intracellular Ca 2þ within cells. However, 10 min. pre-incubation with curcumin can significantly potentiate the Ca 2þ transients response of the ligand activated a 7 -nACh receptors suggesting that curcumin functions as a positive modulator of a 7 -nACh receptors. Since, Ca 2þ transients induced by high K þ containing solutions and activation of a 4 b 2 nACh receptors were not altered by pre-incubation with 10 mM curcumin, the effects of curcumin appear specific to a 7 -nACh receptors.
Interestingly, these functional effects of curcumin appeared dependent on its application prior to the receptor ligand as evidenced by our finding that co-application of curcumin and choline does not alter the choline-induced Ca 2þ transients. Although the kinetics of curcumin effect were not studied in detail in this report, our comparison of the effect of curcumin application (before and during) choline stimulation of the receptor indicates that the potentiating effects of curcumin are achieved after several seconds of ligand preexposure. This time dependent effect of curcumin on the choline response of the nACh receptor suggests that additional cellular pathways upstream of the receptor are engaged by curcumin in these cells. However, inhibition of key nACh receptor modulating kinases such as protein kinase A, C, and CaM by specific inhibitors did not reverse the effect of curcumin suggesting that phosphorylation by the kinases is not required for curcumin's effects on the nACh receptor. In the future studies, it will be important to test the effects of curcumin on other pathways including those pathways that have been demonstrated to be activated by curcumin such as several integral membrane proteins including enzymes, transporters, and ion channels (Zhang et al., 2014) . Notably, the results of radioligand binding experiments indicate that curcumin does alter specific binding of [ 125 I] a-bungarotoxin suggesting that curcumin may act as allosteric modulator of a 7 -nACh receptor. In this study, curcumin was applied in the concentration range of 10 nM to 10 mM and was found that it can enhance the function of a 7 -nACh receptors in a concentration-dependent transients in SH-EP1 cells expressing a 7 -nACh receptor. SH-EP1 cells were preincubated for 30 min with Go-6 983 (specific protein kinase C inhibitor, Go; 3 mM), KT-5 720 (specific protein kinase A inhibitor, KT; 3 mM), and KN-62 (specific inhibitor of CaM kinase II, KN; 10 mM). Bars represent the mean % potentiation ± S.E.M. n ¼ 18e21. manner with EC 50 value of 231 nM. Interestingly, even the major metabolites of curcumin tetrahydrocurcumin, demethylcurcumin, and didemethylcurcumin (Anand et al., 2007) can also potentiate the choline-induced Ca 2þ transients, suggesting bioactivity of these curcumin metabolites at the a 7 -nACh receptor site. The concentration of curcumin in plasma and its ability to pass the blood brain barrier following oral and intravenous administration has been studied previously (Shoba et al., 1998; Anand et al., 2007) . When curcumin is given orally at a dose of 2 g/kg to rats, maximum serum concentration of 1.35 mg/ml (3.5 mM) was attained (Shoba et al., 1998) . Since curcumin is a highly lipophilic compound with LogP (octanolewater partition coefficient) value of 3.3, its membrane concentration is expected to be considerably higher than blood levels. Therefore, the functional modulation of a 7 -nACh receptors demonstrated in this study can be pharmacologically relevant.
